Backgrounds: With the advancement of science and technology in the field of minimal access surgery and refinement of techniques in laparoscopic resection of rectal cancer, it has been widely accepted that the procedure is technically feasible. The safety and oncologic efficacy of laparoscopic colonic cancer resection have been demonstrated. However, the availability of review and data are scarce in evaluating the perioperative safety and long-term oncologic outcome between laparoscopic surgery in the setting of rectal cancer and open approach.
INTRODUCTION
In the current age of minimally invasive surgery, laparoscopic surgery (LPS) for colon cancer has been established as oncologically equivalent to conventional open surgery. The advantages of laparoscopic surgery have translated into smaller incisions and shorter recovery. However, regarding rectal cancer surgery, laparoscopic resection encounters far more challenges mainly due to steep learning curve and technical challenges including difficulties for pelvic exposure, rectal dissection, sphincter preservation and more importantly a lack of long-term data from large scale randomized controled trail (RCT) series.
CONVERSION RATE
In general, rectal cancer surgery is associated with high morbidity and mortality rates as compared to colon cancer surgery. The addition of total mesorectal excision (TME) reduces the local recurrence rate, but complete removal of mesorectum down to the pelvic floor devascularizes the rectal stump and increases anastomotic leak predisposing to higher mortality and morbidity. However, the safety of laparoscopic rectal cancer surgery has been extensively reported in the literature. In a recent Cochrane review of 4,424 patients from 48 studies comparing laparoscopic vs open TME for rectal cancer, Breukink reported no significant differences in morbidity and mortality rates with several short-term advantages in favor of laparoscopic resection, such as less blood loss, quicker return to normal diet, less pain as measured by narcotic use and reduced length of hospital stay. 1 Among larger series, the morbidity and mortality rates of laparoscopic resection for rectal cancer ranged from 6.1 to 40% and 0 to 3% respectively. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] All reports comparing laparoscopic vs open rectal cancer resection, including laparoscopic resection and APR, found no difference in morbidity and mortality. The feasibility of any laparoscopic procedure is reflected by the associated conversion rate. It is a very important marker for laparoscopic success. The reported conversion rate of laparoscopic resection for rectal cancer generally range from 6 to 15.5%. 13 
PORT-SITE METASTASIS
The actual overall incidence of port-site metastasis is a rare event and about 0.1% from reviews and meta-analysis on this subject. 16, 21, 22 This figure is comparable to that of wound recurrence following open surgery. 23, 24 According to these findings, port-site metastasis is not an inherent drawback of LPS for rectal cancer.
LYMPH NODES HARVESTED
A proper oncologic curative resection of rectal cancer requires the adequate resection of regional lymph nodes. Retrieved lymph nodes are associated with improved survival and increased accuracy in staging. From most of the previous comparative studies, the mean number of lymph nodes retrieved ranges from 10 to 13.3 and that there was no significant difference compared with the open procedure. 3, 5, 9, 10, 13 In fact, there is an RCT trial which reported a difference in favor of laparoscopic TME.
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LOCAL RECURRENCE
Local recurrence is a key indicator of oncological adequacy in rectal cancer surgery which varies dramatically among surgeons, the surgical technique being a major determinant. In open surgery, the standard for local recurrence has been set by Heald et al 26 who reported a 4% local recurrence rate following low anterior resection of the rectum and TME with 10 years follow-up. The majority of the studies found similar local recurrence rates ranging from 3.9 to 5.9% for laparoscopic rectal resection.
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LONG-TERM OUTCOME
Long-term survival data following laparoscopic resection of the rectum are scanty in the literature. The majority of long-term outcome data refer to a single surgeon experience series or comparative studies and only five RCT studies focusing on this subject are currently available with different length of median follow-up period with figures ranging from 33.1 to 87.2 months. 14, 18, 25, 29, 30 Data from these series reported no difference in terms of local recurrence, overall and disease-free survival among groups. 32 reported in a comparative monocenter series with a median follow-up of 34 months in patients with stage II and III rectal cancer, a 5-year actuarial survival of 71% in the laparoscopic group compared to a 59% survival rate in the open group, also identifying laparoscopy as one of the independent significant factors associated with better survival at the multivariate analysis.
CONCLUSION
Based on the available data in literature, the mini-invasive approach to rectal cancer surgery is safe and feasible and does not seem to confer any disadvantage in term of local recurrence. With the recently concluded 5-year analysis of MRC CLASICC trial, laparoscopic resection of rectal cancer proves to be oncologically safe and does not compromise the long-term oncological results. The use of laparoscopic rectal surgery should be exploited to fully maximize favorable short-term outcomes and the long-term oncological results.
